Multicolor interphase cytogenetics for the study of plasma cell dyscrasias

Oncology Reports

Volumn 18, Issue 5, 2007, Pages 1099-1106

  Sáez, Borja ^a,b   Martín Subero, José I ^b   Odero, María D ^a,c   Prosper, Felipe ^d   Cigudosa, Juan C ^e   Schoch, Robert ^b   Calasanz, María J ^a   Siebert, Reiner ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF NAVARRA   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

^e Structural Biology and Biocomputing Programme   (Spain)

Author keywords

Fluorescence immunophenotyping; In situ hybridization; Interphase cytogenetics; Multiple myeloma

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

AGED; ARTICLE; CHROMOSOME 11; CHROMOSOME 14; CHROMOSOME ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETICS; HUMAN; INTERPHASE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIA; PATHOLOGY; PLASMA CELL;

AGED; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS; PLASMA CELLS; TRANSLOCATION, GENETIC;

EID: 38449110927     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bergsagel PL and Kuehl WM: Chromosome translocations in multiple myeloma. Oncogene 20: 5611-5622, 2001.
2. Zojer N, Konigsberg R, Ackermann J, Fritz E, Dallinger S, Kromer E, Kaufmann H, Riedl L, Gisslinger H, Schreiber S, Heinz R, Ludwig H, Huber H and Drach J: Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood 95: 1925-1930, 2000. (Pubitemid 30151627)
3. Avet-Louseau H, Daviet A, Sauner S and Bataille R: Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13. Br J Haematol 111: 1116-1117, 2000. (Pubitemid 32104926)
4. Shaughnessy J, Tian E, Sawyer J, Bumm K, Landes R, Badros A, Morris C, Tricot G, Epstein J and Barlogie B: High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood 96: 1505-1511, 2000. (Pubitemid 30658483)
5. Avet-Loiseau H, Li JY, Morineau N, Facon T, Brigaudeau C, Harousseau JL, Grosbois B and Bataille R: Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome. Blood 94: 2583-2589, 1999. (Pubitemid 29477286)
6. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD Jr, Stewart AK and Avet-Loiseau H: Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 64: 1546-1558, 2004. (Pubitemid 38235629)
7. Kuehl WM and Bergsagel PL: Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2: 175-187, 2002. (Pubitemid 37328787)
8. Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA, Dewald GW, Van Ness B, Van Wier SA, Henderson KJ, Bailey RJ and Greipp PR: Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 101: 4569-4575, 2003. (Pubitemid 36857829)
9. Gertz MA, Lacy MQ, Dispenzieri A, Greipp PR, Litzow MR, Henderson KJ, Van Wier SA, Ahmann GJ and Fonseca R: Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy. Blood 106: 2837-2840, 2005. (Pubitemid 41510761)
10. Weber-Matthiesen K, Winkemann M, Muller-Hermelink A, Schlegelberger B and Grote W: Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem 40: 171-175, 1992.
11. Martin-Subero JI, Chudoba I, Harder L, Gesk S, Grote W, Novo FJ, Calasanz MJ and Siebert R: Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses. Am J Pathol 161: 413-420, 2002. (Pubitemid 36142150)
12. Jackson N, Lowe J, Ball J, Bromidge E, Ling NR, Larkins S, Griffith MJ and Franklin IM: Two new IgA1-kappa plasma cell leukaemia cell lines (JJN-1 & JJN-2) which proliferate in response to B cell stimulatory factor 2. Clin Exp Immunol 75: 93-99, 1989. (Pubitemid 19058781)
13. Sonoki T, Harder L, Horsman DE, Karran L, Taniguchi I, Willis TG, Gesk S, Steinemann D, Zucca E, Schlegelberger B, Sole F, Mungall AJ, Gascoyne RD, Siebert R and Dyer MJ: Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood 98: 2837-2844, 2001.
14. Martin-Subero J, Harder L, Gesk S, Schlegelberger B, Grote W, Martinez-Climent J, Dyer M, Novo F, Calasanz M and Siebert R: Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci. Int J Cancer 98: 470-474, 2002. (Pubitemid 34188693)
15. Bentz M, Cabot G, Moos M, Speicher MR, Ganser A, Lichter P and Dohner H: Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 83: 1922-1928, 1994. (Pubitemid 24107917)
16. Hatzivassiliou G, Miller I, Takizawa J, Palanisamy N, Rao PH, Iida S, Tagawa S, Taniwaki M, Russo J, Neri A, Cattoretti G, Clynes R, Mendelsohn C, Chaganti RS and Dalla-Favera R: IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14: 277-289, 2001. (Pubitemid 32289292)
17. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL and Kuehl WM: Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93: 13931-13936, 1996. (Pubitemid 26424223)
18. Yoshida S, Nakazawa N, Iida S, Hayami Y, Sato S, Wakita A, Shimizu S, Taniwaki M and Ueda R: Detection of MUM1/IRF4-IgH fusion in multiple myeloma. Leukemia 13: 1812-1816, 1999. (Pubitemid 29535265)
19. Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schrock E, Ried T and Kuehl WM: Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91: 4457-4463, 1998. (Pubitemid 28270291)
20. Hanamura I, Iida S, Akano Y, Hayami Y, Kato M, Miura K, Harada S, Banno S, Wakita A, Kiyoi H, Naoe T, Shimizu S, Sonta SI, Nitta M, Taniwaki M and Ueda R: Ectopic expression of MAFB gene in human myeloma cells carrying (14;20) (q32;q11) chromosomal translocations. Jpn J Cancer Res 92: 638-644, 2001. (Pubitemid 32633466)
21. Wuilleme S, Robillard N, Lode L, Magrangeas F, Beris H, Harousseau JL, Proffitt J, Minvielle S and Avet-Loiseau H: Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma. Leukemia 19: 275-278, 2005. (Pubitemid 40220593)